| Table 2. Optimized MR-HSG protocol. (FOV and MATRIX numbers it the table represent average values; some adjustments were made according to each patient's biotype). | |||||||
| Study phase | Sequence | Plane | RT(ms) | ET (ms) | FOV (cm) | Thickness (mm) | Matrix |
|---|---|---|---|---|---|---|---|
| 1.Unhanced | 3D-SPACE T2 | Coronal | 1200 | 112 | 36.0 x 57.7 | 1 | 384 x 384 |
| T2 | Axial | 8520 | 135 | 24.0 x 38.5 | 4 | 640 x 640 | |
| T1 fat saturated (VIBE) | Axial | 4.57 | 1.46 | 33.3 x 52.9 | 2 | 260 x 320 | |
| T1 fat saturated (VIBE) | Sagittal | 3.06 | 1.23 | 26.0 x 41.7 | 3 | 320 x 260 | |
| 2. Dynamic with intrauterine contrast injection | VIBE (perfusion) | Axial | 4.08 | 1.23 | 26.0 x 41.7 | 2 | 384 x 384 |
| Early post contrast | Axial | 3.71 | 1.69 | 33.0 x 52.9 | 1.3 | 256 x 256 | |
| 3.Cottê (late phase) | T1 GRE fat saturated (VIBE) | Axial | 4.57 | 1.46 | 32.0 X 51.3 | 2 | 260 x 320 |